DHFR-IN-24
DHFR-IN-24, a benzothiazole derivative, is a dihydrofolate reductase (DHFR) inhibitor. DHFR-IN-24 has intrinsic antibacterial activity against both Gram-positive and Gram-negative strains. DHFR-IN-24 synergistically combines DHFR inhibition with photodynamic therapy (PDT) for enhanced antibacterial activity against multidrug-resistant pathogens[1].
Product Specifications
CAS Number
1088704-78-2
UNSPSC
12352005
Target
Bacterial; Dihydrofolate reductase (DHFR)
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
CN(C1=CC=C(C=C1)C2=CC=C(S2)/C=C/C3=[N+](C4=CC=CC=C4S3)C)C.[I-]
Molecular Formula
C22H21IN2S2
Molecular Weight
504.45
References & Citations
[1]Yang S, et al. Photo-Augmented DHFR Inhibition: N-Methylbenzothiazole Derivatives against Resistant Gram ± Bacteria. ACS Infect Dis. 2025;11 (12) :3567-3580.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV669198 1.0 µg DNA
FGFR2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details cAP-1278 1 Frozen Vial
CHO-K1/HEK293 Cells Stable expressing GPCR protein LTB4R2 (Protein accession # NM_019839)
Sign In for Pricing
View Details 
143448-01 5 µg
Neuropoietin, Recombinant, Mouse (NPO, NP) discontinued
Sign In for Pricing
View Details